GGrantIndex
← Search

ANTIPROLIFERATIVE AND ANTI-INFLAMMATORY ER AGENTS FOR TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER

$452,774FY2013Department of DefenseDOD

University Of Illinois

Investigators

View source on USAspending →
ANTIPROLIFERATIVE AND ANTI-INFLAMMATORY ER AGENTS FOR TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER · GrantIndex